Application of 1001401-62-2,Some common heterocyclic compound, 1001401-62-2, name is 2-(2H-1,2,3-Triazol-2-yl)benzoic acid, molecular formula is C9H7N3O2, traditional synthetic route has been very mature, but the traditional synthetic route has various shortcomings, such as complicated route, low yield, poor purity, etc, below Introduce a new synthetic route.
[( ?)-3-(3-lodo-benzyl)-morpholin-4-yl]-(2-[1 ,2,3]triazol-2-yl-phenyl)-methanone (B-28)A solution of (R)-3-(3-iodo-benzyl)-morpholine B-5 (100 mg, 0.33 mmol) and DIPEA (57 muIota_, 0.33 mmol) in DMF (1.5 mL) was added to a RT solution of 2-(2H-1 ,2,3-triazol-2-yl)benzoic acid E-2 (62 mg, 0.33 mmol), TBTU (1 1 1 mg, 0.35 mmol) and DIPEA (57 muIota_, 0.33 mmol) in DMF (1.5 ml) under argon and the resulting mixture was stirred for 22h. The reaction mixture was quenched with sat. aq. NaHC03 and stirred for 10 min before being diluted with water and extracted with DCM (3x). The combined organic extracts were washed with 2M aq . NaOH (1x), 2M aq. HCI (1 x) and brine (1x), dried over Na2S04, filtered and evaporated in vacuo. The crude product was purified by prep. HPLC (method F) to give the title compound as a white solid. LC-MS D: tR = 0.93 min; [M+H]+ = 474.91 .
The synthetic route of 1001401-62-2 has been constantly updated, and we look forward to future research findings.
Reference:
Patent; ACTELION PHARMACEUTICALS LTD; BOLLI, Martin; BOSS, Christoph; BROTSCHI, Christine; HEIDMANN, Bibia; SIFFERLEN, Thierry; WILLIAMS, Jodi T.; WO2013/68935; (2013); A1;,
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics